Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
Moodys
US Army
Boehringer Ingelheim
Fish and Richardson
Chinese Patent Office
Johnson and Johnson
McKinsey
Daiichi Sankyo

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019281

« Back to Dashboard

NDA 019281 describes CYKLOKAPRON, which is a drug marketed by Pharmacia And Upjohn and is included in two NDAs. It is available from one supplier. Additional details are available on the CYKLOKAPRON profile page.

The generic ingredient in CYKLOKAPRON is tranexamic acid. There are seven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the tranexamic acid profile page.
Summary for 019281
Tradename:CYKLOKAPRON
Applicant:Pharmacia And Upjohn
Ingredient:tranexamic acid
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details
Pharmacology for NDA: 019281
Physiological EffectDecreased Fibrinolysis
Medical Subject Heading (MeSH) Categories for 019281
Suppliers and Packaging for NDA: 019281
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYKLOKAPRON tranexamic acid INJECTABLE;INJECTION 019281 NDA Pharmacia and Upjohn Company LLC 0013-1114 0013-1114-21 10 CARTON in 1 BOX (0013-1114-21) > 1 VIAL in 1 CARTON (0013-1114-20) > 10 mL in 1 VIAL
CYKLOKAPRON tranexamic acid INJECTABLE;INJECTION 019281 NDA Pharmacia and Upjohn Company LLC 0013-1114 0013-1114-10 10 CARTON in 1 BOX (0013-1114-10) > 1 AMPULE in 1 CARTON (0013-1114-01) > 10 mL in 1 AMPULE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength100MG/ML
Approval Date:Dec 30, 1986TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Covington
US Army
Moodys
Chinese Patent Office
Chubb
Colorcon
Express Scripts
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot